ITeos Therapeutics (NASDAQ:ITOS) reported quarterly earnings of $1.98 per share. This is a 6.45 percent increase over earnings of $1.86 per share from the same period last year.
US Steel’s Bid Review Buzz: Evaluates Confidential Buyout Offers
United States Steel Corp (NYSE: X) has reportedly engaged in confidentiality agreements with several interested parties and has begun sharing due diligence information.
This strategic move comes as U.S. Steel evaluates bids for the entire company or specific parts of its operations.
